Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | progesterone receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0057 | 0.0954 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0113 | 0.3536 | 0.3536 |
Echinococcus multilocularis | geminin | 0.0196 | 0.7332 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0077 | 0.19 | 0.19 |
Schistosoma mansoni | hypothetical protein | 0.0196 | 0.7332 | 0.7332 |
Schistosoma mansoni | hypothetical protein | 0.0196 | 0.7332 | 0.7332 |
Loa Loa (eye worm) | TAR-binding protein | 0.0144 | 0.4937 | 0.4937 |
Schistosoma mansoni | ets-related | 0.0255 | 1 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0144 | 0.4937 | 0.6733 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0057 | 0.0954 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0057 | 0.0954 | 0.5 |
Trypanosoma brucei | protein kinase, putative | 0.0057 | 0.0954 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0144 | 0.4937 | 0.4937 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0144 | 0.4937 | 0.4937 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0057 | 0.0954 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0113 | 0.3536 | 0.3536 |
Schistosoma mansoni | tar DNA-binding protein | 0.0144 | 0.4937 | 0.4937 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0057 | 0.0954 | 0.0954 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0057 | 0.0954 | 0.5 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0057 | 0.0954 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0072 | 0.164 | 0.164 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0144 | 0.4937 | 0.4937 |
Schistosoma mansoni | tar DNA-binding protein | 0.0144 | 0.4937 | 0.4937 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0057 | 0.0954 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0057 | 0.0954 | 0.1301 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0084 | 0.2196 | 0.2196 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0057 | 0.0954 | 0.1301 |
Echinococcus multilocularis | tar DNA binding protein | 0.0144 | 0.4937 | 0.6733 |
Schistosoma mansoni | tar DNA-binding protein | 0.0144 | 0.4937 | 0.4937 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0084 | 0.2196 | 0.2995 |
Brugia malayi | Ets-domain containing protein | 0.0084 | 0.2196 | 0.2196 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0057 | 0.0954 | 0.1301 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0057 | 0.0954 | 0.5 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0057 | 0.0954 | 0.5 |
Brugia malayi | RNA binding protein | 0.0144 | 0.4937 | 0.4937 |
Echinococcus granulosus | geminin | 0.0196 | 0.7332 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0057 | 0.0954 | 0.1301 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0057 | 0.0954 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0144 | 0.4937 | 0.4937 |
Brugia malayi | MAP kinase sur-1 | 0.0057 | 0.0954 | 0.0954 |
Brugia malayi | Ets-domain containing protein | 0.0084 | 0.2196 | 0.2196 |
Loa Loa (eye worm) | hypothetical protein | 0.0113 | 0.3536 | 0.3536 |
Loa Loa (eye worm) | RNA binding protein | 0.0144 | 0.4937 | 0.4937 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0084 | 0.2196 | 0.2995 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.19 | 0.19 |
Schistosoma mansoni | gabp alpha | 0.0084 | 0.2196 | 0.2196 |
Loa Loa (eye worm) | fli-1 protein | 0.0255 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0057 | 0.0954 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0077 | 0.19 | 0.19 |
Brugia malayi | TAR-binding protein | 0.0144 | 0.4937 | 0.4937 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0057 | 0.0954 | 0.0954 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0057 | 0.0954 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0113 | 0.3536 | 0.3536 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0057 | 0.0954 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 14 nM | Agonistic activity against human progesterone receptor in CV-1 cells | ChEMBL. | 12954062 |
EC50 (functional) | = 14 nM | Agonistic activity against human progesterone receptor in CV-1 cells | ChEMBL. | 12954062 |
EC50 (functional) | = 161 nM | Agonistic activity against human progesterone receptor in T47D breast cancer cells | ChEMBL. | 12954062 |
EC50 (functional) | = 161 nM | Agonistic activity against human progesterone receptor in T47D breast cancer cells | ChEMBL. | 12954062 |
Efficacy (functional) | = 56 % | Percent agonistic effect towards human progesterone receptor in T47D breast cancer cells | ChEMBL. | 12954062 |
Efficacy (functional) | = 56 % | Percent agonistic effect towards human progesterone receptor in T47D breast cancer cells | ChEMBL. | 12954062 |
Efficacy (functional) | = 127 % | Percent agonistic effect towards human progesterone receptor in CV-1 cells | ChEMBL. | 12954062 |
Efficacy (functional) | = 127 % | Percent agonistic effect towards human progesterone receptor in CV-1 cells | ChEMBL. | 12954062 |
Ki (binding) | = 45.5 nM | Binding affinity towards human progesterone receptor A isoform using progesterone as radioligand | ChEMBL. | 12954062 |
Ki (binding) | = 45.5 nM | Binding affinity towards human progesterone receptor A isoform using progesterone as radioligand | ChEMBL. | 12954062 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.